Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan, +17

The Lancet Infectious Diseases

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Zhiwei Wu, Yaling Hu, Miao Xu, +12

The Lancet Infectious Diseases

A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71

Xiangxi Wang, Wei Peng, Jingshan Ren, +16

Nature Structural & Molecular Biology

Virus StructureMolecular VirologyPathogenesisSensor-adaptor MechanismVirology +2

Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China

Hua Wang, Zijian Feng, Yuelong Shu, +26

The Lancet

VaccinationVirus EpidemiologyEmergent VirusVirologyVirus Transmission +2

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials

Gang Zeng, Qianhui Wu, Hongxing Pan, +15

The Lancet Infectious Diseases

VaccinationVaccine SafetyCoronary UnitThird DoseClinical Trials +6

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial

Jiangtao Lin, Jiansan Zhang, Xiao‐Ping Dong, +18

The Lancet

VaccinationVaccine SafetyVaccine DevelopmentImmunologyInfluenza Vaccine +4

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial

Xiaofeng Liang, Huaqing Wang, Junzhi Wang, +20

The Lancet

VaccinationVaccine SafetyCross-protectionInternational HealthPlacebo-controlled Trial +8

Hepatitis A virus and the origins of picornaviruses

Xiangxi Wang, Jingshan Ren, Qiang Gao, +9

Nature

HepatitisVirologyVirus ClassificationVirus PhylogenyMedicine +1

Safety and Immunogenicity from a Phase I Trial of Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine

Jiangtao Lin, Jiansan Zhang, Nan Su, +24

Antiviral Therapy

Picornavirus uncoating intermediate captured in atomic detail

Jingshan Ren, Xiangxi Wang, Zhongyu Hu, +16

Nature Communications